FDA label
What is Creon used for?
Creon contains pancrelipase amylase, pancrelipase lipase and pancrelipase protease. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “CREON® is indicated for the treatment of exocrine pancreatic insufficiency in adult and pediatric patients.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Creon?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Creon, capsule, delayed release pellets
Indications and Usage, quoted from the label by AbbVie Inc. (BLA020725). Cross-references to other label sections are left out.
CREON® is indicated for the treatment of exocrine pancreatic insufficiency in adult and pediatric patients.
Source: DailyMed label, set id 073201aa-556d-4a70-918e-84e9616fd88d, version 109, effective February 28, 2024. NDC 0032-0046, one of 4 listings for this product.
Questions
What is Creon used for?
The FDA label says: “CREON® is indicated for the treatment of exocrine pancreatic insufficiency in adult and pediatric patients.”
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.